InterveXion and UAMS Complete First Drug Tests in Humans for Methamphetamine Addiction

LITTLE ROCK – InterveXion Therapeutics LLC and the University of Arkansas for Medical Sciences (UAMS) have successfully completed dosing in the first human safety study of a medication to help methamphetamine users fight their addictions.